Serapha Bio Reports Positive Interim SERP-01 Trial Data
Serapha Bio said interim safety and efficacy data from its SERP-01 investigator-initiated trial were presented at the ERS Alpha-1 Antitrypsin Conference 2026.
Serapha Bio said interim safety and efficacy data from its SERP-01 investigator-initiated trial were presented at the ERS Alpha-1 Antitrypsin Conference 2026.